Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 78 Suppl 1, 14-19

Pharmacologic Treatments for Binge-Eating Disorder

Affiliations
Review

Pharmacologic Treatments for Binge-Eating Disorder

Susan L McElroy. J Clin Psychiatry.

Abstract

Binge-eating disorder (BED) is the most common eating disorder and is associated with poor physical and mental health outcomes. Psychological and behavioral interventions have been a mainstay of treatment for BED, but as understanding of this disorder has grown, pharmacologic agents have become promising treatment options for some patients. At this time, only one drug-the stimulant prodrug lisdexamfetamine-is approved for the treatment of BED. Numerous classes of medications including antidepressants, anticonvulsants, and antiobesity drugs have been explored as off-label treatments for BED with variable success. Although not all patients with BED may be suitable candidates for pharmacotherapy, all patients should be considered for and educated about pharmacologic treatment options.

Similar articles

See all similar articles

Cited by 7 articles

See all "Cited by" articles

Substances

LinkOut - more resources

Feedback